News & Trends - Biotechnology

Safety protections for faecal microbiota transplant (FMT)

Health Industry Hub | April 29, 2020 |
[Total: 1    Average: 4/5]

Biotech News: The Therapeutic Goods Administration (TGA) is providing advice on safety protections to faecal microbiota transplant (FMT) providers since there is the potential to transmit the SARS-CoV-2 virus via FMT through shedding in stool.

This advice follows a recent safety alert from the US FDA that highlighted the additional safety precautions that should be in place for COVID-19 disease screening of potential stool donors for FMT products in order to prevent the spread of the SARS-CoV-2 virus.

The draft FMT donor standards on which the TGA recently consulted included a requirement to notify the TGA of measures put in place to manage such epidemiological situations once they are in effect.

The TGA is advising providers of FMT products that they should introduce the following safety measures:

  • Donor screening must include questions directed at identifying stool donors who may be currently or recently infected with the SARS-CoV-2 virus.
  • Stool donors must be tested for the SARS-CoV-2 virus (via stool sample or nasal PCR), as feasible.
  • Criteria for exclusion of stool donors and donor stool based on screening and testing must be developed.
  • Informed consent of patients who undergo FMT must include information about the potential for transmission of the SARS-CoV-2 virus via FMT, including FMT prepared from the stool of donors who are asymptomatic for COVID-19 disease.

Register FREE and join 22,000+ industry professionals receiving the latest industry news and engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

Providers of FMT products are also expected to regularly monitor the TGA website for safety advice updates relating to the use of FMT during the COVID-19 pandemic. The TGA has a dedicated COVID-19 page and also regularly publishes Medicine Safety Update (MSU) articles and safety alerts.

TGA Oversight of FMT Products

By definition, FMT products comprise, contain, or are derived from donated human stool and are introduced into a recipient person for a therapeutic use. Human stool is collected from a screened donor by defaecation. This stool is then processed into an FMT product and provided to the recipient via enema, colonoscopy, nasoenteric tube, or orally (e.g. capsules).

The TGA has recently moved to increase oversight of FMT product supply in Australia, with the sector currently subject to a transition period to allow time for current providers to understand how the changes will impact them, allow them time to comply, and ensure ongoing access for Australian patients.

HCP engagement during COVID-19. Fill the gap of reduced field force activities. Health Industry Hub combines expertise in delivering digital health content with high engagement and 20+ years industry experience. Created by industry for industry. Contact us.

About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Pharmaceuticals

Pharma News - 20 biopharmaceutical companies enter a ground-breaking partnership - AMR Action Fund

20 biopharmaceutical companies enter a ground-breaking partnership

Health Industry Hub | July 10, 2020 |

Please log in to Health Industry Hub to view this content in the ‘News & Trends’ menu.

Health Industry Hub is Australia’s ONLY one-stop-hub connecting Pharma, Biotech and MedTech industry professionals. Learn more.


Market Research & Insights

Market Research Pharma Biotech MedTech - Incredible breadth of Australia’s COVID-19 research: From vaccines to aircon filters

Incredible breadth of Australia’s COVID-19 research: From vaccines to aircon filters

Health Industry Hub | July 9, 2020 |

Market Research & Insights: Since the coronavirus hit Australia’s shores, health and medical researchers have been rapidly redeployed in unprecedented […]



Pharma Biotech Medtech Mentoring - Award-winning IMNIS program fosters collaboration and innovation between industry and academia

Award-winning IMNIS program fosters collaboration and innovation between industry and academia

Health Industry Hub | July 9, 2020 |

Mentoring: The Industry Mentoring Network in STEM (IMNIS) provides PhD student mentees an understanding of the industry sector, strengthen their […]



Communication Public Relations Pharma Biotech Medtech - The changing landscape of Pharma corporate communications - interview

The changing landscape of corporate communications in the Pharma industry

Health Industry Hub | July 8, 2020 |

COVID-19 has had a dramatic impact on the role and nature of healthcare communications, especially following the recent bushfire crisis […]